Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 208-554-7 | CAS number: 533-15-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2016-05-08 - 2016-06-24 (experimental phase)
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Version / remarks:
- Adopted: 17th December 2001
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Slovak National Accreditation Service
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- 1-methylpiperidine-2-ethanol
- EC Number:
- 208-554-7
- EC Name:
- 1-methylpiperidine-2-ethanol
- Cas Number:
- 533-15-3
- Molecular formula:
- C8H17NO
- IUPAC Name:
- 2-(1-methylpiperidin-2-yl)ethanol
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature (20 ± 5°C); keep away from light
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Velaz Prague, Czech Republic
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 180 - 200 g
- Fasting period before study: yes, overnight
- Housing: The animals were housed in plastic cages suspended on stainless steel racks, up to 3 animals per cage in a room equipped with central air-conditioning. Bedding was Lignocel S3/4, Lufa - ITL GmbH, Germany
- Diet (e.g. ad libitum): A laboratory food Altromin (Altromin Spezialfutter GmbH, Germany) was offered in recommended doses each day approximately at the same time.
- Water (e.g. ad libitum): The animals received tap water for human consumption. Supply of drinking was unlimited. The quality of drinking water is periodical analysed (including microbiological control) and recorded.
- Acclimation period: The animals were acclimated under the conditions identical to the conditions during the experiment 5 days prior to the start of treatment.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2° C
- Humidity (%): 55 ± 10 %
- Photoperiod (hrs dark / hrs light): 12-hour light /12-hour dark cycle
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- VEHICLE
- Justification for choice of vehicle: Olive Oil is a standard vehicle according to OECD TG 423
- Lot/batch no. (if required): L52897
DOSAGE PREPARATION (if unusual):
The required amount of the Test Item (according to the body weight and dose) was mixed with vehicle (Olive Oil) shortly before administration. - Doses:
- 2000, 300 mg/kg bw
- No. of animals per sex per dose:
- 3 females for the 2000 mg/kg dose, 6 females for the 300 mg/kg dose
- Control animals:
- no
- Remarks:
- not required
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed individually immediately after the administration of the Test Item and then 0.5, 1, 2, and 4 hours later. Then each animal was inspected daily for the next 14 days. Observations included changes in skin and fur, eyes and mucous membranes, and also respiratory, circulatory, autonomic and central nervous systems, and somatomotor activity and behaviour pattern. Attention was directed to observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
Individual weights of animals were determined shortly before the Test Item was administered and weekly thereafter. Weight differences after first and second weeks after administration were calculated and recorded.
- Necropsy of survivors performed: Yes. All test animals were subjected to gross necropsy. Full, detailed gross necropsy included careful examination of external surface of the body, all orifices, and cranial, thoracic and abdominal cavities and their contents. All gross pathological changes were recorded for each animal.
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- female
- Dose descriptor:
- LD50 cut-off
- Effect level:
- 500 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other:
- Remarks:
- Based on Annex 2d Test Procedure with a Starting Dose of 2000 mg/kg of OECD Guideline 423 it can be concluded that the Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) is classified in Category 4 with a LD50 cut off value 500 mg/kg.
- Sex:
- female
- Dose descriptor:
- LD100
- Effect level:
- <= 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD0
- Effect level:
- >= 300 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Mortality of all 3/3 females at limit dose of 2000 mg/kg was noted. All 6/6 females survived the dose of 300 mg/kg.
- Clinical signs:
- other: Half an hour after treatment with the limit dose of 2000 mg/kg animals were sleepy and lethargic. This behaviour was observed also after 1 and 2 hours. At the next control time point (4 hours), all animals were found dead. Time of animals death was betwee
- Gross pathology:
- All animals were necropsied. During necropsy, marked enlargement of adrenals were noticed in 3/3 animals treated with dose of 2000 mg/kg.
In 2/6 animals treated with dose of 300 mg/kg moderate enlargement of adrenals and a marked bloating in all intestine segments in one animal were registered. No macroscopic changes were noticed in 3/6 animals.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The study was conducted under GLP according to OECD guideline 423 on the registered substance itself. The method is to be considered scientifically reasonable with no deficiencies in documentation or any deviations. Hence, the results can be considered as reliable to assess the acute toxicity of 2-(1-methylpiperidin-2yl) ethanol, (MPA) in rats.
The Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) administered to 3 females at dose of 2000 mg/kg caused sleepiness, lethargy and finally death of all animals within 2 - 4 hours after treatment. During necropsy, marked enlargement of adrenals was found.
The Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) administered to 6 females at dose of 300 mg/kg did not cause death.
Hence, it can be concluded that the LD50 of the Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) is higher than 300 mg/kg and lower than 2000 mg/kg body weight after single oral administration to Wistar rats.
Based on Annex 2d Test Procedure with a Starting Dose of 2000 mg/kg of OECD Guideline 423 it can be concluded that the Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) is classified in Category 4 with a LD50 cut-off value 500 mg/kg, after single oral administration to Wistar rats. - Executive summary:
The purpose of the study was to evaluate the potential toxic effect of the Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) when administered as a single oral dose to Wistar rats.
The procedure according to OECD Guideline 423 Acute Toxic Class (ATC) method was used. A limit dose of 2000 mg/kg was used as a starting dose. One group of 3 females was dosed. The Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) administered to 3 females at dose of 2000 mg/kg caused sleepiness, lethargy and finally death of all animals within 2 - 4 hours after treatment. The necropsy showed marked enlargement of adrenals.
Because test item-related mortality was observed during the first 4 hours, in the next 2 steps, 6 females were treated with the dose of 300 mg/kg. All 6 females survived this dose. The Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) administered to 6 females at dose of 300 mg/kg did not cause death. No body weight losses were observed in 5/6 females one and two weeks after administration of the Test Item. No signs of toxicity were observed in 5/6 females during the first 4 hours or the subsequent 14-day observation period. During necropsy moderate enlargement of adrenals in 2/6 animals and in 1/6 animal marked bloating in all intestine segments were noticed. No macroscopically changes were found in 3/6 animals.
The LD50 of the Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) is higher than 300 mg/kg and lower than 2000 mg/kg body weight after single oral administration to Wistar rats.
Based on Annex 2d Test Procedure with a Starting Dose of 2000 mg/kg of OECD Guideline 423 it can be concluded that the Test Item 2-(1-methylpiperidin-2yl) ethanol, (MPA) is classified in Category 4 with a LD50 cutoff value 500 mg/kg, after single oral administration to Wistar rats.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
